Chronic Obstructive Pulmonary Disease
📧 Sign up to get email alerts when something new happens for Chronic Obstructive Pulmonary Disease.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2015-11-30FDA Approved: BUDESONIDE — Supplemental Application (Chartwell RX, LLC)
The FDA approved a supplemental application for Budesonide from Chartwell RX, LLC, authorizing a change to an existing generic product.
-
FDA approval · 2015-11-24FDA Approved: DALIRESP — Supplemental Application (AstraZeneca Pharmaceuticals LP)
FDA approves a supplemental application for Daliresp (roflumilast) submitted by AstraZeneca.
-
FDA approval · 2015-11-18FDA Approved: IPRATROPIUM BROMIDE — Supplemental Application (Apotex Corp.)
FDA approved Apotex Corp.'s supplemental application for ipratropium bromide (generic) under ANDA 076155. The approval concerns a supplement…
-
FDA approval · 2015-10-26FDA Approved: SPIRIVA HANDIHALER — Supplemental Application (Boehringer Ingelheim Pharmaceuticals, Inc.)
FDA approved a supplemental application for Spiriva HandiHaler (tiotropium bromide) submitted by Boehringer Ingelheim Pharmaceuticals, Inc.
-
FDA approval · 2015-10-21FDA Approved: BREO ELLIPTA — Supplemental Application (GlaxoSmithKline LLC)
FDA approved a supplemental application for Breo Ellipta (fluticasone furoate and vilanterol trifenenate) submitted by GlaxoSmithKline.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2015-09-18FDA Approved: DULERA — Supplemental Application (Organon LLC)
The FDA approved a supplemental application for DULERA (mometasone furoate and formoterol fumarate dihydrate) submitted by Organon LLC.
-
FDA approval · 2015-09-15FDA Approved: SPIRIVA RESPIMAT — Original Application (Boehringer Ingelheim Pharmaceuticals, Inc.)
FDA approved SPIRIVA RESPIMAT (tiotropium bromide inhalation spray) from Boehringer Ingelheim as an Original Application, marking its initia…
-
FDA approval · 2015-09-15FDA Approved: BREO ELLIPTA — Supplemental Application (GlaxoSmithKline LLC)
FDA approved a supplemental application for BREO ELLIPTA (fluticasone furoate and vilanterol) from GlaxoSmithKline, resulting in label chang…
-
FDA approval · 2015-08-27FDA Approved: UMECLIDINIUM AND VILANTEROL ELLIPTA — Supplemental Application (Prasco Laboratories)
FDA approved a supplemental application for Umeclidinium bromide and vilanterol trifenenate in the Ellipta inhaler, enabling Prasco Laborato…
-
FDA approval · 2015-08-14FDA Approved: VENTOLIN HFA — Supplemental Application (GlaxoSmithKline LLC)
FDA approved a supplemental application for Ventolin HFA (albuterol sulfate) from GlaxoSmithKline LLC.
-
FDA approval · 2015-08-07FDA Approved: UMECLIDINIUM AND VILANTEROL ELLIPTA — Supplemental Application (Prasco Laboratories)
FDA approved Prasco Laboratories' supplemental application to market a generic umeclidinium bromide and vilanterol triflate inhalation combi…
-
FDA approval · 2015-08-06FDA Approved: DULERA — Supplemental Application (Organon LLC)
FDA approved a supplemental application for Dulera (momatasone furoate and formoterol fumarate dihydrate) submitted by Organon LLC.
-
FDA approval · 2015-07-30FDA Approved: PROAIR DIGIHALER — Supplemental Application (Teva Respiratory, LLC)
The FDA approved a supplemental application for PROAIR DIGIHALER (albuterol sulfate) submitted by Teva Respiratory, LLC.
-
FDA approval · 2015-07-16FDA Approved: PULMICORT FLEXHALER — Supplemental Application (H2-Pharma LLC)
The FDA has approved a supplemental application for Pulmicort Flexhaler (budesonide) submitted by H2-Pharma LLC.
-
FDA approval · 2015-07-09FDA Approved: COMBIVENT RESPIMAT — Supplemental Application (Boehringer Ingelheim Pharmaceuticals, Inc.)
FDA approved a supplemental application for Combivent Respimat (ipratropium bromide and albuterol) from Boehringer Ingelheim Pharmaceuticals…
-
FDA approval · 2015-06-16FDA Approved: STIOLTO RESPIMAT — Supplemental Application (Boehringer Ingelheim Pharmaceuticals, Inc.)
FDA approved a supplemental application for STIOLTO RESPIMAT (tiotropium bromide and olodaterol) by Boehringer Ingelheim Pharmaceuticals, up…
-
FDA approval · 2015-05-21FDA Approved: STIOLTO RESPIMAT — Original Application (Boehringer Ingelheim Pharmaceuticals, Inc.)
The FDA approved STIOLTO RESPIMAT (tiotropium bromide and olodaterol) as an original application for the maintenance treatment of chronic ob…
-
FDA approval · 2015-04-30FDA Approved: BREO ELLIPTA — Supplemental Application (GlaxoSmithKline LLC)
FDA approved a supplemental application for Breo Ellipta (fluticasone furoate and vilanterol) from GlaxoSmithKline, updating its labeling/in…
-
FDA approval · 2015-04-23FDA Approved: DULERA — Supplemental Application (Organon LLC)
FDA approved a supplemental application for DULERA (mometasone furoate and formoterol fumarate dihydrate) filed by Organon LLC.
-
FDA approval · 2015-04-22FDA Approved: SPIRIVA HANDIHALER — Supplemental Application (Boehringer Ingelheim Pharmaceuticals, Inc.)
The FDA approved a supplemental application for SPIRIVA HANDIHALER (tiotropium bromide) from Boehringer Ingelheim Pharmaceuticals, Inc., fin…
-
FDA approval · 2015-04-14FDA Approved: BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE — Supplemental Application (AstraZeneca Pharmaceuticals LP)
FDA approved a supplemental application for budesonide/formoterol fumarate dihydrate from AstraZeneca Pharmaceuticals LP.
-
FDA approval · 2015-04-03FDA Approved: TUDORZA PRESSAIR — Supplemental Application (Covis Pharma US, Inc)
FDA approved a supplemental application for Tudorza Pressair (aclidinium bromide) submitted by Covis Pharma US, Inc., marking an updated app…
-
FDA approval · 2015-03-31FDA Approved: PROAIR DIGIHALER — Original Application (Teva Respiratory, LLC)
FDA approved PROAIR DIGIHALER (albuterol sulfate) from Teva Respiratory under an Original Application, introducing a digital inhaler version…
-
FDA approval · 2015-03-12FDA Approved: XOPENEX HFA — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approved a supplemental application for XOPENEX HFA (levalbuterol tartrate) from Lupin Pharmaceuticals, approving changes to the product…
-
FDA approval · 2015-03-09FDA Approved: COMBIVENT RESPIMAT — Supplemental Application (Boehringer Ingelheim Pharmaceuticals, Inc.)
The FDA approved a supplemental application for Combivent Respimat (ipratropium bromide and albuterol) submitted by Boehringer Ingelheim Pha…